These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 24362890)

  • 1. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation.
    Vander Lugt B; Khan AA; Hackney JA; Agrawal S; Lesch J; Zhou M; Lee WP; Park S; Xu M; DeVoss J; Spooner CJ; Chalouni C; Delamarre L; Mellman I; Singh H
    Nat Immunol; 2014 Feb; 15(2):161-7. PubMed ID: 24362890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
    Stober D; Jomantaite I; Schirmbeck R; Reimann J
    J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA.
    Pan H; O'Brien TF; Wright G; Yang J; Shin J; Wright KL; Zhong XP
    J Immunol; 2013 Jul; 191(2):699-707. PubMed ID: 23776173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.
    Tanaka Y; Koido S; Ohana M; Liu C; Gong J
    J Immunol; 2005 Feb; 174(3):1274-80. PubMed ID: 15661883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.
    Caminschi I; Vremec D; Ahmet F; Lahoud MH; Villadangos JA; Murphy KM; Heath WR; Shortman K
    Mol Immunol; 2012 Feb; 50(1-2):9-17. PubMed ID: 22209163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.
    You Z; Huang XF; Hester J; Rollins L; Rooney C; Chen SY
    J Immunol; 2000 Oct; 165(8):4581-91. PubMed ID: 11035100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells.
    Schnell S; Young JW; Houghton AN; Sadelain M
    J Immunol; 2000 Feb; 164(3):1243-50. PubMed ID: 10640737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy.
    Teramoto K; Ohshio Y; Fujita T; Hanaoka J; Kontani K
    J Cancer Res Clin Oncol; 2013 May; 139(5):861-70. PubMed ID: 23411688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of IRF8 (Interferon Regulatory Factor 8)-Dependent Dendritic Cells Abrogates Proatherogenic Adaptive Immunity.
    Clément M; Haddad Y; Raffort J; Lareyre F; Newland SA; Master L; Harrison J; Ozsvar-Kozma M; Bruneval P; Binder CJ; Taleb S; Mallat Z
    Circ Res; 2018 Mar; 122(6):813-820. PubMed ID: 29436389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.
    Xiang J; Huang H; Liu Y
    J Immunol; 2005 Jun; 174(12):7497-505. PubMed ID: 15944248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF8 Transcription-Factor-Dependent Classical Dendritic Cells Are Essential for Intestinal T Cell Homeostasis.
    Luda KM; Joeris T; Persson EK; Rivollier A; Demiri M; Sitnik KM; Pool L; Holm JB; Melo-Gonzalez F; Richter L; Lambrecht BN; Kristiansen K; Travis MA; Svensson-Frej M; Kotarsky K; Agace WW
    Immunity; 2016 Apr; 44(4):860-74. PubMed ID: 27067057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
    Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
    J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
    Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
    J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrogen strategy for presentation of an intracellular tumor antigen as an exogenous antigen by dendritic cells induces potent antitumor T helper and CTL responses.
    You Z; Hester J; Rollins L; Spagnoli GC; van der Bruggen P; Chen SY
    Cancer Res; 2001 Jan; 61(1):197-205. PubMed ID: 11196161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens.
    Livingstone AM; Kuhn M
    Eur J Immunol; 1999 Sep; 29(9):2826-34. PubMed ID: 10508257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
    Lemos MP; Fan L; Lo D; Laufer TM
    J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.